SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-049192
Filing Date
2021-04-12
Accepted
2021-04-12 10:00:35
Documents
3
Period of Report
2021-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2112465d1_def14a.htm DEF 14A 550262
2 GRAPHIC tm2112465d1_def14a-img01.jpg GRAPHIC 256866
3 GRAPHIC tm2112465d1_def14a-img02.jpg GRAPHIC 191241
  Complete submission text file 0001104659-21-049192.txt   1168685
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10113 | Film No.: 21819670
SIC: 2834 Pharmaceutical Preparations